Advanced Therapy Medicinal Products Market Report: Trends, Forecast and Competitive Analysis to 2030

Advanced Therapy Medicinal Products Market Report: Trends, Forecast and Competitive Analysis to 2030


Advanced Therapy Medicinal Products Trends and Forecast

The future of the global advanced therapy medicinal products market looks promising with opportunities in the cell therapy, CAR-T therapy, gene therapy, and tissue engineered product markets. The global advanced therapy medicinal products market is expected to reach an estimated $19.9 billion by 2030 with a CAGR of 13.5% from 2024 to 2030. The major drivers for this market are rising healthcare spending, increasing prevalence of chronic diseases, and favorable regulatory environment and growing government support.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Advanced Therapy Medicinal Products by Segment

The study includes a forecast for the global advanced therapy medicinal products by product and region.

Advanced Therapy Medicinal Products Market by Product [Shipment Analysis by Value from 2018 to 2030]:
  • Cell Therapy
  • CAR-T Therapy
  • Gene Therapy
  • Tissue Engineered Product
Advanced Therapy Medicinal Products Market by Region [Shipment Analysis by Value from 2018 to 2030]:
  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World
List of Advanced Therapy Medicinal Products Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies advanced therapy medicinal products companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the advanced therapy medicinal products companies profiled in this report include-
  • Spark Therapeutics
  • Bluebird Bio
  • Novartis
  • Uniqure
  • Celgene Corporation
  • Gilead Lifesciences
  • Kolon Tissuegene
  • JCR Pharmaceuticals
  • Medipost
  • Vericel Corporation
Advanced Therapy Medicinal Products Market Insights

Lucintel forecasts that tissue engineered product will remain the largest segment due to its increasing adoption in wound healing and regenerative medicine applications.

North America will remain the largest segment due to high prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurodegenerative diseases.

Features of the Global Advanced Therapy Medicinal Products Market

Market Size Estimates: Advanced therapy medicinal products market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Advanced therapy medicinal products size by product and region in terms of value ($B).

Regional Analysis: Advanced therapy medicinal products market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products and regions for the mucopolysaccharidosis treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the advanced therapy medicinal products market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the advanced therapy medicinal products market size?

Answer: The global advanced therapy medicinal products market is expected to reach an estimated $19.9 billion by 2030.

Q.2 What is the growth forecast for advanced therapy medicinal products market?

Answer: The global advanced therapy medicinal products market is expected to grow with a CAGR of 13.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the advanced therapy medicinal products market?

Answer: The major drivers for this market are rising healthcare spending, increasing prevalence of chronic diseases and favorable regulatory environment and growing government support.

Q4. What are the major segments for advanced therapy medicinal products market?

Answer: The future of the advanced therapy medicinal products market looks promising with opportunities in the cell therapy, CAR-T therapy, gene therapy, and tissue engineered product markets.

Q5. Who are the key advanced therapy medicinal products market companies?

Answer: Some of the key advanced therapy medicinal products companies are as follows:
  • Spark Therapeutics
  • Bluebird Bio
  • Novartis
  • Uniqure
  • Celgene Corporation
  • Gilead Lifesciences
  • Kolon Tissuegene
  • JCR Pharmaceuticals
  • Medipost
  • Vericel Corporation
Q6. Which advanced therapy medicinal products market segment will be the largest in future?

Answer: Lucintel forecasts that tissue engineered product will remain the largest segment due to its increasing adoption in wound healing and regenerative medicine applications.

Q7. In advanced therapy medicinal products market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment due to high prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurodegenerative diseases.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the advanced therapy medicinal products market by product (cell therapy, CAR-T therapy, gene therapy, and tissue engineered product), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.


1. Executive Summary
2. Global Advanced Therapy Medicinal Products Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Advanced Therapy Medicinal Products Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Advanced Therapy Medicinal Products Market by Product
3.3.1: Cell Therapy
3.3.2: CAR-T Therapy
3.3.3: Gene Therapy
3.3.4: Tissue Engineered Product
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Advanced Therapy Medicinal Products Market by Region
4.2: North American Advanced Therapy Medicinal Products Market
4.3: European Advanced Therapy Medicinal Products Market
4.3.1: European Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product
4.4: APAC Advanced Therapy Medicinal Products Market
4.4.1: APAC Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product
4.5: ROW Advanced Therapy Medicinal Products Market
4.5.1: ROW Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Advanced Therapy Medicinal Products Market by Product
6.1.2: Growth Opportunities for the Global Advanced Therapy Medicinal Products Market by Region
6.2: Emerging Trends in the Global Advanced Therapy Medicinal Products Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Advanced Therapy Medicinal Products Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Advanced Therapy Medicinal Products Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Spark Therapeutics
7.2: Bluebird Bio
7.3: Novartis
7.4: UniQure
7.5: Celgene Corporation
7.6: Gilead Lifesciences
7.7: Kolon TissueGene
7.8: JCR Pharmaceuticals
7.9: MEDIPOST
7.10: Vericel Corporation

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings